Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Ph1 Randomized Double-Blind Controlled Dose-Range Safety Tolerability & Immunogenicity Study of 2 Doses of Intranasal rH5 Flu Vaccine With & Without Nanoemulsion Adjuvant Followed by 1 Boost of Intramuscular H5N1 Vaccine in Healthy Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05397119
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-07-31T00:09:52.118602+00:00
Published At
2026-07-30T00:00:00+00:00
Record Updated At
2026-07-30
Results Posted At
2026-07-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Influenza, Pandemic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-07-30"
protocolSection.identificationModule.nctId
"NCT05397119"
protocolSection.identificationModule.officialTitle
"A Ph1 Randomized Double-Blind Controlled Dose-Range Safety Tolerability \u0026 Immunogenicity Study of 2 Doses of Intranasal rH5 Flu Vaccine With \u0026 Without Nanoemulsion Adjuvant Followed by 1 Boost of Intramuscular H5N1 Vaccine in Healthy Adults"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-07-30"

Study condition terms

  • Influenza, Pandemic (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.